A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease. (2022)

First Author: Poupon-Bejuit L
Attributed to:  The development of gene therapy for Niemann-Pick type C disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-17338-1

PubMed Identifier: 35970890

Publication URI: http://europepmc.org/abstract/MED/35970890

Type: Journal Article/Review

Volume: 12

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322